News Focus
News Focus
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

Re: None

Wednesday, 05/09/2012 5:15:00 PM

Wednesday, May 09, 2012 5:15:00 PM

Post# of 20689
Outlook for 2012 US Copaxone sales (three posts):

#msg-75390703
#msg-75406710
#msg-75406857

The bottom line, IMO, is that 2012 US sales of Copaxone (assuming no generic) will be in the neighborhood of $2.6B.

According to Teva, in 1Q12, Copaxone had a 40.2% TRX share of the US market—the highest of any MS drug.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”